Gold seed implantation in prostate brachytherapy.
Interstitial brachytherapy for treatment of prostate cancer with radioactive gold--initially with liquid gold and later with seed technique--is based on an experience of more than four decades. With biopsy results approaching a 80% negative rate, and, at 5 years, a cancer specific survival of 100% for Stages A and B1, 90% for Stage B2, and 76% for Stage C, this form of treatment offers an effective and well-tolerated alternative mode of therapy for patients with localized prostate cancer.
Loening
S A
SA
Department of Urology, Charité Medical School, Humboldt University, Berlin, Germany. loening@rz.charite.hu-berlin.de
D000230:Adenocarcinoma / Q000401:mortality / Q000532:radiotherapy*; D000368:Aged; D001918:Brachytherapy; D006050:Gold Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D015233:Models, Statistical; D009364:Neoplasm Recurrence, Local; D011471:Prostatic Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D015996:Survival Rate
D006050:Gold Radioisotopes